1. 刘湘源，于清宏，施桂英，等．骨关节炎患者血清及滑液透明质酸的变化．中华风湿病学杂志，1998，2（1）：25.

2. 张长杰．可聚蛋白多糖与骨关节炎．国外医学·物理医学与康复学分册，1998，18（2）：4.

3. 姚力，周乙雄，赵丹惠，等．软骨代谢标志物对骨关节炎软骨代谢改变的反映．创伤骨科论坛，2001，30（1）：19.

4. 邓廉夫．正常关节软骨的胶原表型与骨关节炎关节软骨的表型异常．国外医学·创伤与外科基本问题分册，1996，17（3）：152.

5. 姚如愚．基质金属蛋白酶与骨关节炎．国外医学·内科学分册，2001，28（4）：159.

6. 邵俊杰．细胞因子与骨关节炎．国外医学·骨科学分册，2001，22（3）：113.

7. 蓝旭，刘雪梅，葛宝丰，等．豚鼠原发性骨性关节炎的血清IGF-1检测及意义．中国矫形外科杂志，2000，7（7）：667.

8. 陆江阳，孙笑非，杨毅，等．老年骨关节炎患者关节软骨和滑膜中转化生长因子β及受体和金属蛋白酶组织抑制物的研究．中华老年医学杂志，2001，20（2）：113.

9. 卫晓恩，杨庆铭，邓廉夫，等．骨关节炎软骨基质蛋白多糖变化的实验研究．中华风湿病学杂志，2002，6（1）：25.

10. 陆宁，曾维权，潘瑾，等．骨关节炎软骨及软骨下骨吡啶并林含量的变化．中国矫形外科杂志，2000，7（2）：143.

11. 管剑龙，旋桂英．基质金属蛋白酶与骨关节炎．中华风湿病学杂志，2000，4（1）：54.

12. 刘湘源．骨关节炎病情活动标记物．中华风湿病学杂志，1998，2（4）：233.

13. Moskowitz，Howell，Altman et al. Noninvasive markers in osteoarthritis. IN：Osteoarthritis. New York，Press. 2000，315-326.

14. Sharif M，George E，Shepstone L，et al. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum 1995，38：760-767.

15. Spector TD，Hart DJ，Nandra D，et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rhuem 1997，40：723-727.

16. Thonar EJ-MA，Lenz ME，Masuda K，Manicourt D-H. Body fluid markers of cartilage metabolism. In：Seibel MJm Robins SP，Bilezikian JP，eds. Dynamics of Bone and Cartilage Metabolism. San Diego，Academic Press，1999，453-464.

17. Thonar Ej-MA，Manicourt D-H，et al. Serum keratan sulfate：a measure of cartilage proteoglycan metabolism. IN：Kuettner KE，Schleyerbach R，Peyron JG，18. Hascall VC，eds. Articular Cartilage and Osteoarthritis. New York，Raven Press，1992，pp 429-445.

18. Sandy JD，Jlannery CR，Neame PJ，Lohmander LS. The structure of fragments in human synovial fluid. Evidence for the involvement in Osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest 1992，89：1512-1516.

19. Thonar EK-MA，Williams JM，Maldonado BA，et al. Serum keratan sulfate concentration as a measure of the catabolism of cartilage proteoglycans. In：Kresina，TF，ed. Monoclinal Antibodies，Cytokines and Arthritis. Mediators of Inflammation and Therapy. New York，Marcel Dekker，1991，373-389.

20. Thonar EJ-MA，Glant T. Serum keratan sulfate— a marker of predisposition to polyarticular osteoarthritis. Clin Biochem 1992，25：175-180.

21. Yoshida K，Miyauchi S，Kikuchi H，et al. Analysis curonan by high-performance liquid chromatography. Anal Biochem 1989，177：327-332.

22. Shinmei M，Inamori Y，Yoshihara Y，et al. The potential of cartilage markers in joint fluid for drug evaluation. In：Kuettner KE，Schleyerbach R，Peyron JG，Hascall VC，eds. Articular Cartilage and Osteoarthritis. New York，Raven Press，1992. pp597-608.

23. Uebelhart D，Schlemmer A，Johansen JS，et al. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridimium cross-links. J Clin Endocrinol Metab 1991，72：367-373.

24. Delmas PD，Schlemmer A，Gineyts E，et al. Urinary excretion of pyridinoline cross-links correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J bone Miner Res 1991，6：639-644.

25. Thonar EJ-MA，Shinmer M，Lohmander LS，Body fluid markers of cartilage changes in osteoarthritis. Rheum Dis Clin North Am 1993，19：635-657.

26. Laurent UB，Fraser JR，Engstrom-laurent A，et al. Catabolism of hyaluronan in the knee joint of the rabbit. Matrix 1992，12：130-136.

27. Levick JR. Synovial fluid. Determinants of volume turnover and material concentration. In：Kuettner KE，Schleyerbach R，Peyron JG，Hascall VC，eds. Articular Cartilage and Osteoarthritis. New York，Raven Press，1992，529-541.

28. Rayan V，Thonar EJ-MA，Chen LM，et al. Regional differences in the rise in blood levels of antigenic keratan sulfate and hyaluronan after chymopapain induced knee joint injury. J Rheumatol 1998，25：521-526.

29. Page-Thomas DP，Bard D，King B，Dingle JT. Clearance of proteoglycan from joint cavities. AnnTheum Dis 1987，46：934-937.

30. Myers SL，O’connor BL，Brandt KD. Accelerated clearance of albumin from the osteoarthritic knee：implications for interpretation of concentrations of “cartilage markers” in synovial fluid. J Rheumatol，1996，23：1744-1748.

31. Thonar TJ-MA，Manicourt D-H，williams JM，et al. Serum Keratan sulfate：a measure of cartilage proteoglycan metabolism. In：Kuettner Ke，Schliyerbach R，Peyron JG，Hascall VC，eds. Articular cartilage and Osteoarthritis. New York，Raven press，1992，pp429-445.

32. Sweet MB，coelho A，Schnitzler CM，et al. Serum keratan sulfate levels in osteoarthritis patients. Arthritis Rheum，1998，31：648-652.

33. Thonar EJ-MA，Shinmei M，Lohmander LS. Body fluid markers of cartilage changes in osteoarthritis. Rheum Dis clin North Am，1993，19：635-657.

34. Mok SS，Masuda K，Hauselmann HJ，et al. synthesized by mature bovine chondrocytes suspended in alginage. Identification of two distinct metabolic matrix pools. J Biol Chem，1994，269：33021-33027.

35. Hauselmann HJ，Masuda K，Hunziker EB，et al. Adult human chondrocytes cultured in alginate from a matrix similar to native human articular cartilage. Am J Physiol，1996，271C742-752.

36. Lihmander LS，Lark MW，Dahlberg L，et al. Cartilage matrix metabolism in osteosrthritis：markers in synovial fluid，serum，and urine. Clin Biochem，1992，25：167-174.

37. Slater RR，Bayliss MT，Lachicwicz PF. Monoclonal antibodies that select biochemical markers of arthritis in humans. Arthritis Rheum，1995，38：655.

38. Lohmander LS，Thonar EJ-MA. Serum keratan sulfate concentrations are different in primary and posttraumatic osteoarthrosis of the knee. Orthop Res Soc Trans，1994，19：459.

39. Haraoui B，Thonar EJ-MA，Martel-Pelletier J，et al. Serum keratan sulfate levels in rheumatoid arthritis：inverse correlation with radiographic staging. J Rheumatol，1994，21：813-817.

40. Lopa S，Madry H. Bioinspired Scaffolds for Osteochondral Regeneration. Tissue Eng Part A. 2014 Jan 29.

41. Pruksakorn D，Tirankgura P，Luevitoonvechkij S，Chamnongkich S，Sugandhavesa N，Leerapun T，Pothacharoen P. Changes in the serum cartilage biomarker levels of healthy adults in response to an uphill walk. Singapore Med J. 2013 Dec；54（12）：702-708.

42. Grenier S，Bhargava MM，Torzilli PA. An in vitro model for the pathological degradation of articular cartilage in osteoarthritis. J Biomech. 2014 Feb 7；47（3）：645-52.

43. Taffetani M，Griebel M，Gastaldi D，Klisch SM，Vena P. Poroviscoelastic finite element model including continuous fiber distribution for the simulation of nanoindentation tests on articular cartilage. J Mech Behav Biomed Mater. 2014 Apr；32：17-30.

44. Ahmed TA，Hincke MT. Mesenchymal stem cell - based tissue engineering strategies for repair of articular cartilage. Histol Histopathol. 2014 Jun；29（6）：669-689.

45. Lohmander LS，Saxne T，Heinegard DK. Release of cartilage oligometric matrix protein（COMP）into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis，1994，513-538.

46. Saxne T，Heinegard D. Cartilage oligomeric matrix protein：a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol，1992，31：583-591.

47. Lohmander LS，Saxne T，Heinegard D. Increased concentrations of bone sialoprotein in joint fluid after knee injury. Ann Rheum Dis，1996，55：622-626.

48. Houssiau FA，Devogelaer JP，Van Damme J，et al. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum，1998，31：784-788.

49. Hsuselmann HJ，Flechtenmacher J，Michal L，et al. The superficial layer of human articular cartilage is more susceptible to interleukin-1-induced damage than the deeper layers. Arthritis Rheum，1996，39：478-488.

50. Fosang AJ，Last K，Maciewicz RA. agrrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and agrrecannase activities can be independent. J Clin invest，1996，98：2292-2299.

51. Thonar EJ-MA，Kuettner KE. Biochemical basis of age-related changes in proteoglycans. In：Wight TN，Mecham RP，eds. The Biplogy of the extracelluar Matrix：Biology of Proteoglycans. New York，Academic Press，1987，211-246.

52. Bleasel JF，Poole AR，Heinegard D，et al. changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type Ⅱ collagen gene COL2A1 mutation. Arthritis Rheum，1999，42：39-45.

53. Petersson IF，Boegard T，Svensson B，et al. Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol，1998，37：46-50.

54. Manicourt D-H，Altman RD，Williams JM，et al. Treatment with calcitonin suppresses the responses of bone，cartilage，and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of cartilage lesions. Arthritis Rheum，1999，42：1159-1167.

55. Thonar EJ-MA，Schnitzer TJ，Kuettner KE. Quantification of keratan sulfate in blood as a marker of cartilage catabolism. J Rhuematol，1987，14：23-24.

56. Dean DD，Martel-Pelletier J，Pelletier J-P，et al. evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest，1989，84：678-685.

57. Manicourt D-H，Lenz ME，Thonar EJ-MA. Levels of serum keratan sulfate rise rapidly and remain elevated following anterior cruciate ligament transection in the dog. J Rheumatol，1991，18：1872-1876.

58. Sandy JD，Adama ME，Billingham MEJ，et al. In vivo and in vitro stimulation of chondrocyte biosynthetic activity in early experimental osteoarthritis. Arthritis Rheum，1984，27：388-397.

59. Rsdin EL，paul IL. Does cartilage compliance reduce skeletal impact loads? Atthritis Rheum，1970，13：139-144.

60. Thompson PW，Spector TD，James IT，et al. Urinary collagen cross-links reflect the radiographic severity of knee osteoarthritis. Br J Rheumatol，1992，31：759-761.

61. Oldberg A，Antonsson P，Lindblom K，et al. COMP（cartilage oligomericmatrix protein）is structurally related to the thrombospondins. J Biol Chem，1992，267（31）：22346-22350.

62. Aigner T，McKenna L. Molecular pathology and pathobiology of osteoarthritic cartilage. Cell Mol Life Sci，2002，59（1）：5-18.

63. Saxne T，Heinegard D. Cartilage ol igomeric matrix protein：a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol，1992，31（9）：583-591.

64. Geng H，Carlsen S，Nandakumar KS，et al. Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis. Arthritis Res Ther，2008，10（6）：134.

65. Hashimoto Y，Tomiyama T，Yamano Y，et al. Mutation（D472Y）in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis. Am J Pathol，2003，163（1）：101-110.

66. Gagarina V，Carlberg AL，Pereira-Mouries L，et al. Cartilage ol igomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteins. J Biol Chem，2008，283（1）：648-659.

67. Wisłowska M，Jabłońska B. Serum cartilage oligomeric matrix protein（COMP）in rheumatoid arthritis and knee osteoarthritis. Cl in Rheumatol，2005，24（3）：278-284.

68. Garnero P，Piperno M，Gineyts E，et al. Cross sectional evaluation of biochemical markers of bone，cartilage，and synovial tissue metabolism in patients with knee osteoarthritis：relations with disease activity andjoint damage. Ann Rheum Dis，2001，60（6）：619-626.

69. Hunter DJ，Li J，LaValley M，et al. Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis：the Boston Osteoarthritis Knee Study. Arthritis Res Ther，2007，9（5）：108.

70. Jansen NW，Roosendaal G，Lundin B，et al. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen，serum cartilage oligomeric matrix protein，and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy. Arthritis Rheum，2009，60（1）：290-298.

71. Fernandes FA，Pucinelli ML，da Silva NP，et al. Serum cartilage oligomeric matrix protein（COMP）levels in knee osteoarthritis in a Brazilian population：cl inical and radiological correlation. Scand J Rheumatol，2007，36（3）：211-215.

72. Chen HC，Shah S，Stabler TV，et al. Biomarkers associated with clinical phenotypes of hand osteoarthritis in a large multigenerational family：the CARRIAGE family study. Osteoarthritis Cartilage，2008，16（9）：1054-1059.

73. Arai K，Tagami M，Hatazoe T，et al. Analysis of cartilage ol igomeric matrix protein（COMP）in synovial fluid，serum and urine from51 racehorses with carpal bone fracture. J Vet Med Sci，2008，70（9）：915-921.

74. Wanner J，Subbaiah R，Skomorovska-Prokvolit Y，Shishani Y，Boilard E，Mohan S，Gillespie R，Miyagi M，Gobezie R. Proteomic profiling and functional characterization of early and late shoulder osteoarthritis. Arthritis Res Ther. 2013 Nov 6；15（6）：R180.

75. Chaganti RK，Kelman A，Lui L，et al. Change in serum measurements of cartilage oligomeric matrix protein and association with the development and worsening of radiographic hip osteoarthritis. Osteoarthritis Cartilage，2008，16（5）：566-571.